<DOC>
	<DOCNO>NCT01214200</DOCNO>
	<brief_summary>The purpose pilot study evaluate effect high intensity non-invasive positive pressure ventilation ( HINPPV ) stable , hypercapnic COPD patient . The investigator believe HINPPV , use least 6 hour nocturnally three month , benefit stable hypercapnic COPD patient reduction daytime partial pressure carbon dioxide arterial blood ( PaCO2 ) level .</brief_summary>
	<brief_title>High Intensity Non-Invasive Positive Pressure Ventilation ( HINPPV )</brief_title>
	<detailed_description>The High Intensity Non-invasive Positive Pressure trial single arm interventional study . The purpose study evaluate effect High Intensity Non-invasive ventilation ( HINPPV ) stable Chronic Obstructive Pulmonary patient chronically elevated carbon dioxide level . Participants undergo various test ( ABGs , PFTs , PSGs , 6 minute walk test ) 3 month period determine type therapy improve daytime carbon dioxide level . The participant also complete quality life questionnaire help ascertain improvement daily living activity .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>Inclusion Criteria 1 . Patient diagnose chronic obstructive pulmonary disease ( COPD ) 2 . Age &lt; = 80 year 3 . Forced expiratory volume one second ( FEV1 ) &lt; 50 % predict value 4 . FEV1/Forced vital capacity ( FVC ) &lt; 70 % predict value 5 . Total lung capacity ( TLC ) &gt; 90 % predict plethysmography 6 . Body Mass Index ( BMI ) &lt; 35 7 . Patient provide write informed consent use form approve Internal Review Board ( IRB ) 8 . Daytime PaCO2 ≥ 52 mm Hg , rest room air ( Denver &gt; 48 mm Hg ) one follow symptom hypercapnia : Fatigue Sleepiness Headaches 9 . Post hospital discharge least one month prior screen visit 10 . Participant willing able complete require assessment procedures 11 . Participant child bear potential OR negative pregnancy test woman childbearing potential Exclusion Criteria 1 . FEV1 &lt; 15 % predict value 2 . Diagnosis obstructive sleep apnea ( OSA ) [ Apnea hypopnea index ( AHI ) &gt; 15 per hour ] 3 . Current Noninvasive Positive Pressure Ventilation ( NIPPV ) , Positive Airway Pressure ( PAP ) Noninvasive Ventilation ( NIV ) users 4 . Signs / symptom acute exacerbation within previous month : two follow criterion : Increasing cough Purulent sputum Current use antibiotic pH &lt; 7.35 5 . Any major non COPD disease condition interfere completion initial followup assessment , uncontrolled malignancy , endstage heart disease , liver renal insufficiency ( require current evaluation liver renal transplantation dialysis ) , amyotrophic lateral sclerosis , severe stroke , deem appropriate investigator determine review medical history / patient report medical history 6 . History pneumothorax 7 . Anatomical facial abnormality preclude placement nasal facial mask 8 . Diffuse parenchymal lung disease emphysema 9 . Inability maintain Oxygen ( O2 ) saturation &gt; 90 % 5L/min nasal O2 rest 10 . Sustained need &gt; 10 mg prednisone daily equivalent dose systemic corticosteroid 11 . Pregnancy 12 . Excessive alcohol intake ( ≥ 6oz hard liquor daily ) , illicit drug use 13 . Daily use narcotic ( great 30 mg morphine equivalent ) 14 . Patient currently enrol another interventional clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2012</verification_date>
</DOC>